Karla Alejandra Espinoza Dueñas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karla Alejandra Espinoza Dueñas has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cynthia Georgina Trejo-Iriarte
Programa de Cirugía Dental, Laboratorio de Investigación en Odontología Almaraz, Facultad de Estudios Superiores Iztacala, UNAM, Cuautitlán Izcalli, México
1 shared publication - Gerardo Leyva-Gómez
Departamento de Farmacia, Facultad de Química Universidad Nacional Autónoma de México Ciudad de México México
1 shared publication - Gloria Soldevila
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico
1 shared publication - Guadalupe Antonio-Ríos
Laboratorios de Producción y Control de Biológico, Biotecnología Molecular y Farmacéutica, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, México
1 shared publication - Maykel González-Torres
Departamento de Ciencias Químicas, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Edo. de México, México
1 shared publication - Rosa María Ribas-Aparicio
Laboratorios de Producción y Control de Biológico, Biotecnología Molecular y Farmacéutica, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas Instituto Politécnico Nacional Ciudad de México México
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (3) , 1051-1066
The Impact of Large-Scale Expansion on the Functional Properties of Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are highly valuable for their potential in cell therapy and tissue engineering because of their self-renewal, multilineage differentiation, and immunomodulatory capabilities. Adipose-derived mesenchymal stem cells (AD-MSCs) are advantageous in regenerative medicine because of their accessibility and ease of isolation. However, the clinical application of MSCs faces challenges related to large-scale culture (LSC) expansion, which is required to generate enough cells for transplantation but also decreases their therapeutic properties. This review assesses the impact of LSC on MSC functionality, differentiation potential, and immunomodulatory properties, and identifies key factors, such as metabolic shifts, genetic instability, and altered secretory profiles, that can compromise their therapeutic potential. We explored how prolonged in vitro passaging decreases MSC functionality and increases the risk of genetic alterations. In addition, strategies to preserve the efficacy of MSCs during scaling are discussed. A comprehensive literature review was conducted using PubMed, focusing on in vitro and in vivo studies that evaluated the effects of LSC on MSCs. These findings provide insights into optimizing culture protocols to maintain the clinical efficacy of AD-MSCs in regenerative therapies, addressing the critical need to balance large-scale expansion and functional integrity. Graphical Abstract
- 6 February 2026
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (3) , 1051-1066
Open AccessThe Impact of Large-Scale Expansion on the Functional Properties of Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are highly valuable for their potential in cell therapy and tissue engineering because of their self-renewal, multilineage differentiation, and immunomodulatory capabilities. Adipose-derived mesenchymal stem cells (AD-MSCs) are advantageous in regenerative medicine because of their accessibility and ease of isolation. However, the clinical application of MSCs faces challenges related to large-scale culture (LSC) expansion, which is required to generate enough cells for transplantation but also decreases their therapeutic properties. This review assesses the impact of LSC on MSC functionality, differentiation potential, and immunomodulatory properties, and identifies key factors, such as metabolic shifts, genetic instability, and altered secretory profiles, that can compromise their therapeutic potential. We explored how prolonged in vitro passaging decreases MSC functionality and increases the risk of genetic alterations. In addition, strategies to preserve the efficacy of MSCs during scaling are discussed. A comprehensive literature review was conducted using PubMed, focusing on in vitro and in vivo studies that evaluated the effects of LSC on MSCs. These findings provide insights into optimizing culture protocols to maintain the clinical efficacy of AD-MSCs in regenerative therapies, addressing the critical need to balance large-scale expansion and functional integrity. Graphical Abstract